106 related articles for article (PubMed ID: 17642499)
1. Potential of commercial anti-D reagents in the identification of partial D variants in Indian population.
Kulkarni SS; Vasantha K; Gupte SC; Mohanty D; Ghosh K
Indian J Med Res; 2007 May; 125(5):641-4. PubMed ID: 17642499
[TBL] [Abstract][Full Text] [Related]
2. Commercial anti-D reagents in Indian market & detection of partial D variants.
Choudhury N
Indian J Med Res; 2007 May; 125(5):615-7. PubMed ID: 17642496
[No Abstract] [Full Text] [Related]
3. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
Williams M
Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
[TBL] [Abstract][Full Text] [Related]
4. Varied distribution of RhD epitopes in the Indian population.
Kulkarni SS; Gupte SC; Vasantha K; Mohanty D; Ghosh K
Natl Med J India; 2007; 20(4):169-71. PubMed ID: 18085120
[TBL] [Abstract][Full Text] [Related]
5. [Reactivity of monoclonal antibodies as blood grouping reagents].
Okubo Y
Nihon Rinsho; 1997 Sep; 55(9):2340-6. PubMed ID: 9301300
[TBL] [Abstract][Full Text] [Related]
6. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
7. Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200.
Jenkins CM; Johnson ST; Bellissimo DB; Gottschall JL
Immunohematology; 2005; 21(4):152-4. PubMed ID: 16472016
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
Judd WJ; Moulds M; Schlanser G
Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
[TBL] [Abstract][Full Text] [Related]
9. Weak D phenotypes and transfusion safety: where do we stand in daily practice?
Noizat-Pirenne F; Verdier M; Lejealle A; Mercadier A; Bonin P; Peltier-Pujol F; Fialaire-Legendre A; Tournamille C; Bierling P; Ansart-Pirenne H
Transfusion; 2007 Sep; 47(9):1616-20. PubMed ID: 17725725
[TBL] [Abstract][Full Text] [Related]
10. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
Credidio DC; Pellegrino J; Castilho L
Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
[TBL] [Abstract][Full Text] [Related]
11. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.
Kulkarni S; Kasiviswanathan V; Ghosh K
Blood Transfus; 2013 Jan; 11(1):37-42. PubMed ID: 22871818
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric quantification of antigen D sites on red blood cells of partial D and weak D variants in India.
Kulkarni S; Mohanty D; Gupte S; Vasantha K; Joshi S
Transfus Med; 2006 Aug; 16(4):285-9. PubMed ID: 16879157
[TBL] [Abstract][Full Text] [Related]
13. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
[TBL] [Abstract][Full Text] [Related]
14. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
[TBL] [Abstract][Full Text] [Related]
15. Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype.
Lai M; Grasso C; Boschi I; D'Onofrio G; Pascali V; Leone G
Transfusion; 2009 May; 49(5):937-42. PubMed ID: 19175552
[TBL] [Abstract][Full Text] [Related]
16. An International Standard for specifying the minimum potency of anti-D blood-grouping reagents: evaluation of a candidate preparation in an international collaborative study.
Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
Vox Sang; 2006 Feb; 90(2):131-9. PubMed ID: 16430672
[TBL] [Abstract][Full Text] [Related]
17. False-positive reactions of some monoclonal anti-c reagents.
Strobel E; Bauer MF
Transfus Med; 2009 Jun; 19(3):141-5. PubMed ID: 19566672
[TBL] [Abstract][Full Text] [Related]
18. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
[TBL] [Abstract][Full Text] [Related]
19. Secondary anti-D immunization by Del red blood cells.
Yasuda H; Ohto H; Sakuma S; Ishikawa Y
Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
[TBL] [Abstract][Full Text] [Related]
20. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
